OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis
Roberta Armignacco, Giulia Cantini, Letizia Canu, et al.
Journal of Endocrinological Investigation (2017) Vol. 41, Iss. 5, pp. 499-507
Closed Access | Times Cited: 19

Showing 19 citing articles:

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial
Benedito A. Carneiro, Bhavana Konda, Rubens B. Costa, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 12, pp. 6193-6200
Open Access | Times Cited: 97

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance
Marta Araujo‐Castro, Eider Pascual‐Corrales, Javier Molina‐Cerrillo, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 304-304
Open Access | Times Cited: 28

Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma
G Poli, Carmen Ruggiero, Giulia Cantini, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 5, pp. 1712-1724
Open Access | Times Cited: 36

How to Differentiate Benign from Malignant Adrenocortical Tumors?
Charlotte L. Viëtor, Sara G Creemers, Folkert J. van Kemenade, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4383-4383
Open Access | Times Cited: 19

Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC
Adwitiya Kar, Yu Zhang, Betelehem W. Yacob, et al.
Endocrine Related Cancer (2019) Vol. 26, Iss. 10, pp. 765-778
Open Access | Times Cited: 19

Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma
Michaela Luconi, Giulia Cantini, Rachel S. van Leeuwaarde, et al.
Endocrine Pathology (2023) Vol. 34, Iss. 2, pp. 224-233
Open Access | Times Cited: 6

The effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells
Beatrice Rubin, Catia Pilon, Raffaele Pezzani, et al.
Journal of Endocrinological Investigation (2019) Vol. 43, Iss. 3, pp. 357-367
Closed Access | Times Cited: 14

Steroid Sulfation in Adrenal Tumors
Jonathan Wolf Mueller, Nora Vogg, Thomas Alec Lightning, et al.
The Journal of Clinical Endocrinology & Metabolism (2021)
Open Access | Times Cited: 12

The next step: mechanisms driving adrenocortical carcinoma metastasis
Enzo Lalli, Michaela Luconi
Endocrine Related Cancer (2017) Vol. 25, Iss. 2, pp. R31-R48
Open Access | Times Cited: 13

Laparoscopic Trans-Abdominal Right Adrenalectomy for a Large Primitive Adrenal Oncocytic Carcinoma: A Case Report and Review of Literature
Valerio Panizzo, Barbara Rubino, Guglielmo Niccolò Piozzi, et al.
American Journal of Case Reports (2018) Vol. 19, pp. 1096-1102
Open Access | Times Cited: 13

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
Giulia Cantini, Laura Fei, Letizia Canu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 9

Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases
Mark J. McCabe, Mark Pinese, Chia‐Ling Chan, et al.
Molecular Case Studies (2019) Vol. 5, Iss. 2, pp. a003764-a003764
Open Access | Times Cited: 8

A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors
Marina Tsoli, Kosmas Daskalakis, Eva Kassi, et al.
Biology (2021) Vol. 10, Iss. 7, pp. 580-580
Open Access | Times Cited: 6

Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2
Rudradip Das, Moumita Ghosh Chowdhury, Sonal Raundal, et al.
Gene (2022) Vol. 822, pp. 146354-146354
Closed Access | Times Cited: 4

Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma
Л С Селиванова, Anna Roslyakova, A. V. Bogolyubova, et al.
Russian Journal of Archive of Pathology (2019) Vol. 81, Iss. 5, pp. 92-92
Closed Access | Times Cited: 5

Adrenocortical Carcinoma
Bülent Orhan, Ömer Dızdar, Şuayib Yalçın, et al.
Springer eBooks (2024), pp. 507-523
Closed Access

Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma
Filippo Crimì, F Turatto, Carlo D’Alessandro, et al.
Journal of Endocrinological Investigation (2024)
Open Access

New targeted therapies for adrenocortical carcinomas
Jacopo Manso, Raffaele Pezzani
Minerva Endocrinologica (2018) Vol. 44, Iss. 1
Closed Access | Times Cited: 2

Identification of Novel Hub Genes Through Expression Profiles Analysis in Adrenocortical Carcinoma
Chenhe Yao, Xiaoling Zhao, Xuemeng Shang, et al.
Research Square (Research Square) (2020)
Open Access

Page 1

Scroll to top